Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

Apolipoprotein E-Mediated Immune Regulation in Sepsis

(2014) O. M. Kattan et al.   JOURNAL OF IMMUNOLOGY

Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes

(2013) Bianca Weinstock-Guttman et al.   JOURNAL OF NEUROIMMUNOLOGY

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

(2013) Bianca Weinstock-Guttman et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study

(2013) Dana Horakova et al.   PLoS One

Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis

(2013) Robert Zivadinov et al.   RADIOLOGY

Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease

(2013) D. M. Holtzman et al.   Cold Spring Harbor Perspectives in Medicine

Closing the case ofAPOEin multiple sclerosis: no association with disease risk in over 29 000 subjects: Figure 1

(2012) Christina M Lill et al.   JOURNAL OF MEDICAL GENETICS

Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent A  Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice

(2012) N. Bien-Ly et al.   JOURNAL OF NEUROSCIENCE

Randomized controlled trial of atorvastatin in clinically isolated syndrome: The STAyCIS study

(2012) E. Waubant et al.   NEUROLOGY

Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis

(2012) Catherine A. Dayger et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study

(2012) Tomas Kalincik et al.   PLoS One

ApoE controls the interface linking lipids and inflammation in atherosclerosis

(2011) Christian Weber et al.   JOURNAL OF CLINICAL INVESTIGATION

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis

(2011) Bianca Weinstock-Guttman et al.   Journal of Neuroinflammation

Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis

(2011) Bianca Weinstock-Guttman et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

(2011) Per Soelberg Sorensen et al.   LANCET NEUROLOGY

A Bayesian model of shape and appearance for subcortical brain segmentation

(2011) Brian Patenaude et al.   NEUROIMAGE

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis

(2011) Robert Zivadinov et al.   NEUROIMAGE

The Immune-Modulatory Role of Apolipoprotein E with Emphasis on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

(2010) Hong-Liang Zhang et al.   Clinical & Developmental Immunology

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

(2010) R. A. Marrie et al.   NEUROLOGY

HDL-cholesterol: Is it really good?

(2008) Carlos G. Santos-Gallego et al.   BIOCHEMICAL PHARMACOLOGY

Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

(2008) John J.P. Kastelein et al.   CIRCULATION

The genetics of clinical outcome in multiple sclerosis

(2008) Sreeram V. Ramagopalan et al.   JOURNAL OF NEUROIMMUNOLOGY

The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment

(2007) M. Andrikoula et al.   DIABETES OBESITY & METABOLISM